Cargando…
A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model
BACKGROUND: Hedgehog (Hh) signaling is over-activated in several solid tumors where it plays a central role in cell growth, stroma recruitment and tumor progression. In the Hh signaling pathway, the Smoothened (SMO) receptor comprises a primary drug target with experimental small molecule SMO antago...
Autores principales: | Strand, Martin F., Wilson, Steven R., Dembinski, Jennifer L., Holsworth, Daniel D., Khvat, Alexander, Okun, Ilya, Petersen, Dirk, Krauss, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115942/ https://www.ncbi.nlm.nih.gov/pubmed/21698280 http://dx.doi.org/10.1371/journal.pone.0019904 |
Ejemplares similares
-
Identification of a potent antagonist of smoothened in hedgehog signaling
por: Fan, Junwan, et al.
Publicado: (2021) -
A Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy
por: Fan, Junwan, et al.
Publicado: (2022) -
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists
por: Frank-Kamenetsky, Maria, et al.
Publicado: (2002) -
Deciphering the Allosteric Effect of Antagonist Vismodegib on Smoothened Receptor Deactivation Using Metadynamics Simulation
por: An, Xiaoli, et al.
Publicado: (2019) -
The Role of Smoothened in Cancer
por: Jeng, Kuo-Shyang, et al.
Publicado: (2020)